Abettor Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 27-06-2024
- Paid Up Capital ₹ 0.10 M
as on 27-06-2024
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.40 M
as on 27-06-2024
- Satisfied Charges ₹ 1.00 M
as on 27-06-2024
- Revenue 31.10%
(FY 2022)
- Profit 99.17%
(FY 2022)
- Ebitda -6.54%
(FY 2022)
- Net Worth 50.90%
(FY 2022)
- Total Assets 14.17%
(FY 2022)
About Abettor Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.40 M. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jaisingh Khatri and Chandrakant Morti serve as directors at the Company.
- CIN/LLPIN
U74900PN2012PTC145440
- Company No.
145440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Abettor Life Sciences Private Limited offer?
Abettor Life Sciences Private Limited offers a wide range of products and services, including Ayurveda Products, Natural Hair & Skin Care.
Who are the key members and board of directors at Abettor Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaisingh Khatri  | Director | 20-Nov-2012 | Current |
| Chandrakant Morti | Director | 20-Nov-2012 | Current |
Financial Performance and Corporate Structure Insights of Abettor Life Sciences.
Abettor Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.1% increase. The company also saw a substantial improvement in profitability, with a 99.17% increase in profit. The company's net worth Soared by an impressive increase of 50.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abettor Life Sciences?
In 2019, Abettor Life Sciences had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Jun 2020 | ₹0.40 M | Open |
Others Creation Date: 31 Mar 2018 | ₹8.00 M | Open |
Bank Of Baroda Creation Date: 05 Nov 2015 | ₹1.00 M | Satisfied |
How Many Employees Work at Abettor Life Sciences?
Abettor Life Sciences has a workforce of 22 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abettor Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abettor Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
